Ann: RC220 Toxicology and Safety Pharmacology Studies Initiated, page-23

I wish you the best of luck, and likewise to all holders.

There is a reason RAC is in the bottom drawer and not sold, because at my relatively quite young age and at a 15% of my portfolio allocation, RAC has the potential to give me a very free life in terms of career choices and financial stability - and needless to say give many others a liberated life who might not know of RAC yet, but might well be acquainted with it in the future.

I think relations between holders on this forum are more and more often turning sour, and while we have some good eggs here, I reckon anyone who believes in the long term trajectory should consider only returning upon announcements, as I now will.